A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men with Metastatic Castration Resistant Prostate Cancer

Type of Cancer
Genito-Urinary

Site
Hackensack

Sponsor
Eli Lilly

Protocol Number
I6A-MC-CBBD (GU 115)

To Learn More Call
201-510-0910